Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center.

Johnson DB, Friedman DL, Berry E, Decker I, Ye F, Zhao S, Morgans AK, Puzanov I, Sosman JA, Lovly CM
Cancer Immunol Res. 2015 3 (5): 464-9

PMID: 25649350 · PMCID: PMC4420706 · DOI:10.1158/2326-6066.CIR-14-0217

MeSH Terms (14)

Antibodies, Monoclonal Antineoplastic Agents Colitis Diarrhea Disease-Free Survival Exanthema Humans Immunotherapy Ipilimumab Melanoma Neuralgia Pituitary Diseases Pruritus Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links